KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) R&D In Process (2016 - 2019)

Bausch Health Companies' R&D In Process history spans 10 years, with the latest figure at $1.0 million for Q1 2019.

  • On a quarterly basis, R&D In Process changed 0.0% to $1.0 million in Q1 2019 year-over-year; TTM through Mar 2019 was $13.0 million, a 7.14% decrease, with the full-year FY2018 number at $1.0 million, down 80.0% from a year prior.
  • R&D In Process hit $1.0 million in Q1 2019 for Bausch Health Companies, roughly flat from $1.0 million in the prior quarter.
  • Over the last five years, R&D In Process for BHC hit a ceiling of $95.8 million in Q3 2015 and a floor of -$20.0 million in Q4 2016.
  • Historically, R&D In Process has averaged $13.7 million across 4 years, with a median of $1.0 million in 2016.
  • Biggest five-year swings in R&D In Process: surged 381.41% in 2015 and later tumbled 852.38% in 2016.
  • Tracing BHC's R&D In Process over 4 years: stood at -$2.1 million in 2015, then tumbled by 852.38% to -$20.0 million in 2016, then soared by 105.0% to $1.0 million in 2018, then changed by 0.0% to $1.0 million in 2019.
  • Business Quant data shows R&D In Process for BHC at $1.0 million in Q1 2019, $1.0 million in Q1 2018, and -$20.0 million in Q4 2016.